[Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations].

Neurol Neurochir Pol

I Kliniki Neurologicznej Instytutu Psychiatrii i Neurologii, Warszawie.

Published: May 1992

The authors analysed the results of controlled treatment by three methods of patients in the 1st or 2nd phase of SSPE in a randomized group. The groups received: I. Propionibacterium granulosum KP-45 (interferon inducer) + isoprinosine, II--TFX (thymus extract) + isoprinosine, III--only isoprinosine. In all groups the treatment was continued during 6 months. The analysis of the clinical results of these methods failed to demonstrate a statistically significant superiority of any of these methods (among others, due to small number of cases) but an evident statistical tendency was revealed suggesting a better effectiveness of combined treatment (immunostimulator + isoprinosine) in relation to treatment with isoprinosine only. The final evaluation of the results requires further observations of these patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

isoprinosine
5
[comparison treatment
4
treatment patients
4
patients sspe
4
sspe immunomodulating
4
immunomodulating preparations]
4
preparations] authors
4
authors analysed
4
analysed controlled
4
treatment
4

Similar Publications

Often ill people are, first of all, patients with recurrent infectious and inflammatory diseases of the upper respiratory tract (URT). They put a significant financial burden on the healthcare system. The leading etiological factors of recurrent inflammatory diseases of URT, in addition to pathogenic bacterial microflora, are viral agents (viruses of the viral respiratory infections group, herpes viruses).

View Article and Find Full Text PDF
Article Synopsis
  • SSPE is a rare, progressive disorder caused by a lingering mutant measles virus in the brain, with unclear treatment strategies among neurologists.
  • A survey of 298 Indian neurologists revealed insights into their management practices, showing varied preferences for therapies such as Isoprinosine and valproate.
  • There is a significant gap in follow-up care for SSPE patients and an urgent need for clearer treatment guidelines to improve patient outcomes.
View Article and Find Full Text PDF

Background: Subacute Sclerosing Panencephalitis (SSPE) is a fatal disorder marked by gradual cognitive and motor deterioration, leading to death typically within 1-3 years.

Case Report: A 20-year-old woman with progressive abnormal behaviour, forgetfulness, and involuntary movements showed significant improvement after treatment with interferon and isoprinosine. Initially severely cognitively impaired and dependent, she regained independence and demonstrated marked cognitive enhancement, her MMSE improved from 15 to 28 and reduced myoclonus.

View Article and Find Full Text PDF
Article Synopsis
  • * There is no definitive cure for SSPE, but a treatment combining intrathecal interferon-α (IFN-α) and oral isoprinosine has shown effectiveness.
  • * A case study of a 24-year-old male with spastic seizure epilepsy highlighted the diagnosis of SSPE through increased measles antibodies in cerebrospinal fluid, abnormal EEG readings, and distinctive MRI findings.
View Article and Find Full Text PDF

This study presents a case of subacute sclerosing panencephalitis (SSPE), a rare neurologic disorder characterized by brain inflammation, typically triggered by measles virus reactivation or an abnormal immune response to it. This case involves a five-year-old male child with persistent fever, declining motor function, excessive sleepiness, and myoclonic jerks. MRI indicated potential ischemic changes or encephalitis, while electroencephalography showed SSPE-consistent patterns.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!